US equities |
MU $877.55 ▲+2.46% NVDA $210.96 ▼-0.59% SPCX $147.49 ▲+1.89% AAPL $347.73 ▼-0.14% TSLA $372.22 ▼-0.63% SNDK $1,238.03 ▼-1.82% META $642.62 ▼-0.96% AMD $516.79 ▲+1.74%
FinancialContent

Latest News about At/Home Therapy

Recent news which mentions At/Home Therapy

LSD Microdosing For Depression? This Clinical Study Reveals Promising Results
Tickers NEWS
Tags Management Benzinga major depressive disorder
From Benzinga
Fibromyalgia Care Breakthrough: DEA Green Lights Biotech Partnership Exploring Ketamine Implant Therapy
Tickers NEWS SILO
Tags Psychedelics SILO Market News
From Benzinga
At-Home Ketamine Therapy Ending Soon And New Survey Finds Overdosing All Too Common
Tags Regulations News Market News
From Benzinga
At-Home Ketamine For Depression: New Study Adds Proof On Its Safety And Efficacy
Tags Psychedelics Market News News
From Benzinga